Adrian Hill trained at Trinity College Dublin and Oxford is now Professor of Human Genetics and Director of the Jenner Institute at Oxford University. He leads research programmes in genetic susceptibility to tropical infectious diseases and in vaccine design and development.
His group identified heterologous prime-boost immunisation using non-replicating vectors as an exceptionally potent approach for inducing protective T cell responses in murine malaria and undertook the first clinical trials of this vaccination strategy. In 2005 he was appointed Director of the Jenner Institute, a new initiative aimed at accelerating public sector vaccine development for a variety of human and livestock infectious diseases. The Institute aims to fill the gap between pre-clinical vaccine design and large-scale field efficacy trials particularly for infections that pose great disease burdens in developing countries. Over fifty clinical trials have been undertaken in recent years by Jenner Investigators who are developing new vaccines against malaria, HIV, tuberculosis, meningitis, pandemic influenza and hepatitis.
He currently also chairs the Centre for Clinical Vaccinology and Tropical Medicine and the Clinical Biomanufacturing Facility in Oxford. He has published over 350 research papers. He is a Fellow of the UK Academy of Medical Sciences and the Royal College of Physicians and a NIHR Senior Investigator.
The majority of material on 'Science sees further' including text, graphics and logos, is copyright. You are free to reproduce the text (but not the images) for non-commercial research or educational purposes only.